MIM
KRRO icon

Monashee Investment Management’s Korro Bio KRRO Stock Holding History

Monashee Investment Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-55,364
Closed -$4.98M – 106
2024
Q1 		$4.98M Sell
55,364
-35,441
-39% -$1.93M 0.59% 29
2023
Q4 		$4.35M Buy
+90,805
New +$2.99M 0.77% 12

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Monashee Investment Management's KRRO Position: Q2 2024 in Review

Monashee Investment Management sold out of Korro Bio (KRRO) in Q2 2024, closing a stake of 55,364 shares — an estimated $4.98M sold.

Monashee Investment Management first reported a position in KRRO in Q4 2023 and held it in 2 quarters. The position peaked at $4.98M in Q1 2024. 64 funds tracked by Wall St. Rank hold KRRO as of Q2 2024.

  • Monashee Investment Management reported no remaining Korro Bio position as of Q2 2024 after selling out during the quarter.
  • Monashee Investment Management sold 55,364 Korro Bio shares in Q2 2024, an estimated $4.98M.
  • Monashee Investment Management first reported a position in Korro Bio in Q4 2023 and held it in 2 quarters.
  • Monashee Investment Management's Korro Bio position peaked at $4.98M in Q1 2024.
  • 64 funds tracked by Wall St. Rank held Korro Bio as of Q2 2024.

Based on Monashee Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.